Suzuki et al. [19] demonstrated a significant decrease in serum ALT levels obtained by intravenous injection of SNMC in patients with chronic hepatitis, and Hirayama et al. [20] showed a significant decrease in serum ALT levels obtained by oral administration of Sho-saiko-to in patients with chronic active hepatitis. Here, GPT is linked to chronic hepatitis.